StonvexLoading…
StonvexStonvexStonvexCore line items from ADNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.51B | $3.64B | $14.54B | $10.85B |
Operating Income | $117.00M | $41.00M | $-88.00M | $-152.00M |
Net Income | $5.00M | $-22.00M | $-281.00M | $-299.00M |
EPS (Diluted) | $0.06 | $-0.28 | $-3.39 | $-3.56 |
Total Assets | $9.03B | $8.77B | $8.95B | $8.84B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $831.00M | $855.00M | $958.00M | $860.00M |
Free Cash Flow OCF − CapEx | $23.00M | $15.00M | $204.00M | $70.00M |
Shares Outstanding | 78.41M | 78.33M | 79.15M | 81.25M |